Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults

NCT02168946 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
77
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)

Collaborators